Nanil Therapeutics Inc

$75,000.00 CAD

≈ 12 months of average Canadian pay

Department: National Research Council Canada
Program: Industrial Research Assistance Program – Contributions to Firms
Recipient country: Canada
Fiscal year: 2025-2026
Agreement period: September 1, 2025 – January 2, 2026
Reference: nrc-cnrc:172-2025-2026-Q2-1034082

Published purpose

Nanil Therapeutics is validating its proprietary BioDesign-AI platform through experimental assessment of AI-generated nanobody sequences targeting tau, a key protein in Alzheimer’s disease.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful

View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions